Related Experiment Video
Updated: Jul 6, 2025

09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
7.7K
New horizons in subdural haematoma
Frances Rickard1, John Gale2, Adam Williams3
1Consultant Geriatrician, Geriatric Major Trauma, North Bristol NHS Trust, Bristol, UK.
Age and Ageing
|January 3, 2024
Summary
Subdural hematoma (SDH) management in frail older adults is complex due to bleeding and clotting risks. Current UK practices vary, highlighting the need for evidence-based guidelines for this vulnerable population.
Area of Science:
- Neurology
- Geriatrics
- Neurosurgery
Background:
- Subdural hematoma (SDH) is common in frail older adults, often resulting from falls.
- Anticoagulant and antiplatelet use in SDH patients presents complex risks of rebleeding and thrombosis.
- Current UK management of SDH is inconsistent, lacking established guidelines.
Purpose of the Study:
- To review current decision-making processes for managing subdural hematoma in older adults with frailty and multimorbidity.
- To evaluate the safety and efficacy of different interventions for acute and chronic SDH in this population.
- To identify gaps in evidence and guide future research for improved SDH management.
Main Methods:
- Review of existing literature on subdural hematoma epidemiology, risk factors, and management strategies in older adults.
- Analysis of outcomes associated with surgical decompression, burr hole drainage, and middle meningeal artery embolisation.
- Assessment of current clinical practices and guideline deficiencies in the UK.
Main Results:
- Surgical decompression for acute SDH has poor outcomes in older adults.
- Burr hole drainage is a potentially safe and effective option for symptomatic chronic SDH (cSDH).
- Middle meningeal artery embolisation shows promise as a minimally invasive option to reduce rebleeding risk.
Conclusions:
- Careful patient assessment is crucial to differentiate cSDH symptoms from other medical conditions.
- Evidence-based guidelines are needed to standardize and optimize SDH management in frail older populations.
- Further randomized controlled trials are essential to inform clinical practice beyond historical observational data.

